Anti-epileptic drug toxicity in children

Anti-epileptic drugs (AEDs) have had a major impact on children, improving their quality of life and significantly reducing both morbidity and mortality. They are, however, associated with significant toxicity. Behavioural problems and somnolence are the most frequent adverse drug reactions for many...

Full description

Bibliographic Details
Main Author: Choonara, Imti
Format: Article
Published: MDPI 2018
Subjects:
Online Access:https://eprints.nottingham.ac.uk/51727/
_version_ 1848798559933038592
author Choonara, Imti
author_facet Choonara, Imti
author_sort Choonara, Imti
building Nottingham Research Data Repository
collection Online Access
description Anti-epileptic drugs (AEDs) have had a major impact on children, improving their quality of life and significantly reducing both morbidity and mortality. They are, however, associated with significant toxicity. Behavioural problems and somnolence are the most frequent adverse drug reactions for many AEDs. Unfortunately, the comparative risk of drug toxicity for different AEDs has been inadequately studied. Drug toxicity is poorly reported in randomised controlled trials. Prospective cohort studies are the best way to study drug toxicity. There have been a few prospective cohort studies of children with epilepsy, but the numbers of children have been small. Systemic reviews of the toxicity of individual AEDs have been helpful in identifying the risk of drug toxicity. Parents of children with epilepsy and the children and young people who are due to receive AED treatment have the right to know the likelihood of them experiencing drug toxicity. Unfortunately, the evidence base on which health professionals can provide such information is limited.
first_indexed 2025-11-14T20:21:42Z
format Article
id nottingham-51727
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:21:42Z
publishDate 2018
publisher MDPI
recordtype eprints
repository_type Digital Repository
spelling nottingham-517272020-05-04T19:35:11Z https://eprints.nottingham.ac.uk/51727/ Anti-epileptic drug toxicity in children Choonara, Imti Anti-epileptic drugs (AEDs) have had a major impact on children, improving their quality of life and significantly reducing both morbidity and mortality. They are, however, associated with significant toxicity. Behavioural problems and somnolence are the most frequent adverse drug reactions for many AEDs. Unfortunately, the comparative risk of drug toxicity for different AEDs has been inadequately studied. Drug toxicity is poorly reported in randomised controlled trials. Prospective cohort studies are the best way to study drug toxicity. There have been a few prospective cohort studies of children with epilepsy, but the numbers of children have been small. Systemic reviews of the toxicity of individual AEDs have been helpful in identifying the risk of drug toxicity. Parents of children with epilepsy and the children and young people who are due to receive AED treatment have the right to know the likelihood of them experiencing drug toxicity. Unfortunately, the evidence base on which health professionals can provide such information is limited. MDPI 2018-05-01 Article PeerReviewed Choonara, Imti (2018) Anti-epileptic drug toxicity in children. Children, 5 (5). pp. 57-59. ISSN 2227-9067 Drug toxicity; Antiepileptic drug; Behavioural problems; Valproate; Lamotrigine; Levetiracetam http://www.mdpi.com/2227-9067/5/5/57 doi:10.3390/children5050057 doi:10.3390/children5050057
spellingShingle Drug toxicity; Antiepileptic drug; Behavioural problems; Valproate; Lamotrigine; Levetiracetam
Choonara, Imti
Anti-epileptic drug toxicity in children
title Anti-epileptic drug toxicity in children
title_full Anti-epileptic drug toxicity in children
title_fullStr Anti-epileptic drug toxicity in children
title_full_unstemmed Anti-epileptic drug toxicity in children
title_short Anti-epileptic drug toxicity in children
title_sort anti-epileptic drug toxicity in children
topic Drug toxicity; Antiepileptic drug; Behavioural problems; Valproate; Lamotrigine; Levetiracetam
url https://eprints.nottingham.ac.uk/51727/
https://eprints.nottingham.ac.uk/51727/
https://eprints.nottingham.ac.uk/51727/